[HTML][HTML] Change of willingness to accept COVID-19 vaccine and reasons of vaccine hesitancy of working people at different waves of local epidemic in Hong Kong …

K Wang, ELY Wong, KF Ho, AWL Cheung, PSY Yau… - Vaccines, 2021 - mdpi.com
Vaccine hesitancy is among the major threats to the effectiveness of vaccination
programmes. This study aimed to report the trend in response to willingness to accept the …

[HTML][HTML] A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine

L Chu, R McPhee, W Huang, H Bennett, R Pajon… - Vaccine, 2021 - Elsevier
Background Vaccines are urgently needed to prevent the global spread of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). We assessed the safety and …

[HTML][HTML] The potential of selected agri-food loss and waste to contribute to a circular economy: Applications in the food, cosmetic and pharmaceutical industries

LLDR Osorio, E Flórez-López, CD Grande-Tovar - Molecules, 2021 - mdpi.com
The food sector includes several large industries such as canned food, pasta, flour, frozen
products, and beverages. Those industries transform agricultural raw materials into added …

[HTML][HTML] A comprehensive review of viral characteristics, transmission, pathophysiology, immune response, and management of SARS-CoV-2 and COVID-19 as a …

CR Triggle, D Bansal, H Ding, MM Islam… - Frontiers in …, 2021 - frontiersin.org
COVID-19 emerged from China in December 2019 and during 2020 spread to every
continent including Antarctica. The coronavirus, SARS-CoV-2, has been identified as the …

[HTML][HTML] Human IgG and IgA responses to COVID-19 mRNA vaccines

AV Wisnewski, JC Luna, CA Redlich - PloS one, 2021 - journals.plos.org
SARS-CoV-2 spike antigen-specific IgG and IgA elicited by infection mediate viral
neutralization and are likely an important component of natural immunity, however, limited …

Psychological and behavioral predictors of vaccine efficacy: considerations for COVID-19

AA Madison, MR Shrout, ME Renna… - Perspectives on …, 2021 - journals.sagepub.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine candidates are
being evaluated, with the goal of conferring immunity on the highest percentage of people …

Neutralising antibody escape of SARS‐CoV‐2 spike protein: risk assessment for antibody‐based Covid‐19 therapeutics and vaccines

D Focosi, F Maggi - Reviews in medical virology, 2021 - Wiley Online Library
The Spike protein is the target of both antibody‐based therapeutics (convalescent plasma,
polyclonal serum, monoclonal antibodies) and vaccines. Mutations in Spike could affect …

[HTML][HTML] Scientific rationale for developing potent RBD-based vaccines targeting COVID-19

H Kleanthous, JM Silverman, KW Makar, IK Yoon… - npj Vaccines, 2021 - nature.com
Vaccination of the global population against COVID-19 is a great scientific, logistical, and
moral challenge. Despite the rapid development and authorization of several full-length …

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals

T Bilich, A Nelde, JS Heitmann, Y Maringer… - Science translational …, 2021 - science.org
Long-term immunological memory to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) is crucial for the development of population-level immunity, which is the aim …

SARS-CoV-2 and the human-animal interface: outbreaks on mink farms

M Koopmans - The Lancet Infectious Diseases, 2021 - thelancet.com
The circulation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had
already been observed several months earlier, but the reason for the policy change was an …